Biotech: Pressemitteilungen - Kategorie - Seite 123

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Immunovaccine Announces Management Team Changes

HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 09/03/13 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE: IMV), a clinical stage vaccine company, today announced t ...

Biosenta's ZeroMold Product to Be Showcased on The Shopping Channel

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 09/03/13 -- Biosenta, Inc. (CNSX: ZRO) (the "Company") is pleased to announce that the Company's ZeroMold retail product line will be featured on ...

Prana Drug Treatment PBT2 Named One of Top Neuroscience Projects to Watch

MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 09/03/13 --PBT2 selected as one of the most attractive neuroscience opportunities in the industryIndependent panel says PBT2 potentially meets a large, unmet m ...

Aptalis Pharma(TM) Launches PYLERA(R) 10 Day Therapy PAK in the United States

BRIDGEWATER, NJ: BRIDGEWATER, NJ -- (Marketwired) -- 09/03/13 -- Aptalis Pharma, US Inc. announces the launch of PYLERA® 10 Day Therapy PAK in the U.S. PYLERA® capsules (bismuth subcitrate potassium, metronidazole, ...

Paladin Announces Increase in Ownership of Litha

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 09/03/13 -- Paladin Labs Inc. (TSX: PLB) ("Paladin") today announced that it has acquired a block of 71,608,625 shares in Litha Healthcare Group Limite ...

Totality of Data From Three Phase III Trials of The Medicines Company's Intravenous Cangrelor Presented and Published

AMSTERDAM, THE NETHERLANDS: Champion Trials Pooled Results Presented at European Society of Cardiology Scientific Session and Published in The Lancet; New Pooled Analysis Shows Cangrelor Demonstrates Reduction in Angiographic Co ...

Critical Outcome Technologies Completes Final Tranche of Private Placement

LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwired) -- 08/30/13 -- Critical Outcome Technologies Inc. (TSX VENTURE: COT) ("COTI" or the "Corporation") announced today that it has completed the thir ...

AB Science : Financial Results and Key Events of First Half-Year 2013

PARIS, FRANCE: PARIS, FRANCE -- (Marketwired) -- 08/30/13 -- (EURONEXT PARIS: AB) (ISIN: FR0010557264)Half-Year Information - First Semester 2013(EURONEXT PARIS: AB) (ISIN: FR0010557264), a pharmaceutical company ...

Med Biogene Announces Discontinuance of Petition by Dissident Shareholders

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 08/30/13 -- Med BioGene Inc. (TSX VENTURE: MBI) today announced that the petition (the "Petition") filed by certain shareholders of MBI agai ...

Nanobiotix Half Year Results for the Period Ended 30 June 2013

PARIS: Small But Heading for a Big Time; Strong Clinical Progress Achieved ...

Endexx's M3Hub(TM) Platform Supports State Legalized Marijuana Laws

CAVE CREEK, AZ: M3Hub(TM) and Dispense Labs LLC Targeting Washington State and Colorado Licensees ...

Genetic Technologies Receives Certification for New York State

MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 08/30/13 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that it has received its Clinical Laboratory Permit from the New Yor ...

Immunovaccine Announces Financial Results for the Quarter Ended June 30, 2013

HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 08/29/13 -- Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE: IMV), a clinical stage vaccine company, today released its financ ...

Ceapro Reports Second Quarter 2013 Financial Results

EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 08/29/13 -- Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the Company") today announced its financial results for the three-month and six-month per ...

Med BioGene Reports Financial Results for Q2 2013

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 08/29/13 -- Med BioGene Inc. (TSX VENTURE: MBI) today reported its financial results for the six months ended June 30, 2013 (all amounts are in United ...

Theravance to Present at Investor Conferences in September 2013

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 08/28/13 -- Theravance, Inc. (NASDAQ: THRX) announced today that Rick E Winningham, Theravance's Chief Executive Officer, is scheduled to present at t ...

Helix BioPharma Corp. Establishes Polish Subsidiary

AURORA, ON: AURORA, ON -- (Marketwired) -- 08/28/13 -- Helix BioPharma Corp. ("Helix") (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatme ...

CytoSorbents to Present at the Rodman & Renshaw Annual Global Investment Conference

MONMOUTH JUNCTION, NJ: MONMOUTH JUNCTION, NJ -- (Marketwired) -- 08/28/13 -- CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company commercializing its European Union approved CytoSorb® blood filter to tr ...

Horizon Pharma Files Patent Infringement Lawsuit Against Watson Laboratories, Inc. - Florida for Filing an ANDA Against RAYOS(R)

DEERFIELD, IL: DEERFIELD, IL -- (Marketwired) -- 08/27/13 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced it, along with SkyePharma from whom it has licensed certain RAYOS intellectual property, has filed a ...

Critical Outcome Technologies Reports Year-End Financial and Operating Results

LONDON, ONTARIO: Key commercialization initiatives advanced during and subsequent to year-end ...


Seite 123 von 255:  « ..  122 123 124  125  126  127  128  129  130  131  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z